|Bid||0.6300 x 0|
|Ask||0.6400 x 0|
|Day's Range||0.5900 - 0.6400|
|52 Week Range||0.1350 - 0.6400|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ovation's new distributor, Grupo Venta International, S.A. de C.V. ("Grupo Venta"), with corporate offices in Guadalajara, Mexico, has made their first purchase of over 10,000 bottles of DermSafe, which they will begin distributing through-out Mexico. DermSafe® is a pharmaceutical-grade hand sanitizer lotion that uses chlorhexidine gluconate; an ingredient used worldwide in hospitals as it has a proven ability to kill germs.
VANCOUVER, BC / ACCESSWIRE / June 15, 2020 / (OVAT.CN) - Ovation Science Inc. ("Ovation" or the "Company") is pleased to announce it has signed a revised agreement for additional rights for its DermSafe hand sanitizer (the "License Renewal Agreement") under the terms of the original License Agreement with Skinvisible Pharmaceuticals, Inc., previously announced February 13, 2020. The License Renewal Agreement provides Ovation with immediate additional rights which will assist in the sales and marketing of the product internationally. The original License Agreement provided Ovation with the exclusive worldwide rights to DermSafe hand sanitizer for an initial period of three years with renewal rights.
This release provides updates to regulatory status, sales, manufacturing, and the science which supports DermSafe. DermSafe has two drug identification numbers (DIN) issued by Health Canada: DIN#02310589 and DIN#02355558 (personal use and personal commercial use). Both of these DINS are exclusively licensed worldwide by Ovation Science Inc. from Skinvisible Pharmaceuticals Inc. DermSafe has also been accepted by Health Canada under its list of "Disinfectants and hand sanitizers accepted under COVID-19 interim measure".
VANCOUVER, BC / ACCESSWIRE / May 1, 2020 / Ovation Science Inc. ("Ovation" or the "Company") (CSE:OVAT) is pleased to announce a proposed private placement offering of up to 4,000,000 ...
Made without alcohol, DermSafe uses chlorhexidine gluconate; an ingredient used worldwide in hospitals as it has a proven ability to kill both bacteria and viruses. The distribution agreement with Gad Medical provides the Company with the opportunity to expand sales of its DermSafe hand sanitizer through an established medical distributor outside of North America.
Ovation will be showcasing its DermSafe® hand sanitizer which is being sold to a growing number of countries around the globe to assist in the battle against the coronavirus. Ovation will be participating with its 20 minute presentation at 9:10 AM PST / 12:10 PM EST, followed by a panel discussion at 10:30 PST / 1:30 EST on opportunities around the COVID crisis and how we are adapting our supply chain to meet demands.
The Company is enjoying a record first quarter which will continue to add shareholder value. The extraordinary opportunity to help fight the coronavirus (Covid-19) pandemic globally is boosting revenues and the Company expects to enjoy several consecutive record quarters. Management has been working diligently these past months to not only expand the Company's diverse operations, but to continue to build on the Company's solid foundation.
This allows the Company to ship directly from the Company's production facility in Nevada and its other contract manufacturers to all major Canadian hubs. To help manage the spread of COVID-19, Health Canada has implemented an interim measure that will facilitate the importation of hand sanitizers. DermSafe is fully compliant with Health Canada and these interim measures now allow the expedited importation of DermSafe from Ovation's US manufacturers and this will ensure a continuous supply.
Due to the seriousness and virulence of the COVID-19 virus, Ovation Science has seen heightened demand for its long-lasting chlorhexidine gluconate hand sanitizing lotion called DermSafe. The hand sanitizer does not contain alcohol. It is specially formulated with chlorhexidine gluconate; an ingredient used worldwide in hospitals as it has a proven ability to kill both bacteria and viruses.
The WHO (World Health Organization) yesterday declared the coronavirus a worldwide pandemic; defined as the "worldwide spread" of a new disease. DermSafe is made with chlorhexidine gluconate; an ingredient used worldwide in hospitals as it has a proven ability to kill both bacteria and viruses. DermSafe binds to the hands and resists wash-off and rub-off for up to 4 hours post application while continuing to kill both bacteria and viruses.
"Ovation is a proud Canadian company and we are grateful it has stepped up as our supplier at this important time." "Sports teams around the world are facing the same question as the CFL; "how do we protect our players and staff?" Protection is paramount for everyone, including washing your hands properly and using a hand sanitizer like DermSafe for persistent protection." DermSafe hand sanitizer has the unique ability to remain on your hands for four hours; killing germs without reapplication.
The recent spread of the coronavirus in China and globally has fueled the demand for this product. " "Independent research conducted at a major virology lab in the UK confirms that DermSafe has both an immediate kill as well as a long term kill of up to 4 hours on envelope viruses tested including H5N1 (bird flu), H1N1 (swine flu) and H3N2 (influenza virus).
Ovation's provisional patent application sets a priority date and protects the Company's invention of a novel and improved composition and method of a transdermal delivery system allowing delivery of cannabinoids through the skin at therapeutic levels. Transdermal delivery is a more efficient method than oral (edibles) or inhalation (smoking or vaping) as it avoids metabolism of the majority of the cannabinoids by the first pass through the liver and delayed onset, which is the case for oral dosage forms, and damage to the lungs by inhalation.
Ovation Science also announces it has entered into an extendable three year, exclusive world-wide licensing agreement with Skinvisible Pharmaceuticals, Inc. to manufacture, market and sell its DermSafe® hand sanitizer. "We are selling our entire first batch of our DermSafe hand sanitizer to a significant Chinese entity, paid in full, and gearing up to fulfill what could be considerable demand, given the dire situation," said Terry Howlett, President of Ovation.
In this advisory role, Dr. Walley will guide the Company in the clinical development of its topical and transdermal cannabinoid products including CBD and THC. Dr. Walley is a clinical development and dermatology expert, having served as a key executive in these fields, for almost three decades.
Nevada's Top Selling CBD Line of Wellness Products Signs Agreements with Various Distribution Partners to Cover Coast to Coast Product Availability LAS VEGAS, NV and VANCOUVER, BC / ACCESSWIRE / December ...
The website provides US consumers the ability to purchase high quality health and wellness products infused with the benefits of hemp-derived CBD (Cannabidiol). Invibe MD will begin with three products: Relief and Relax, Keep Fit Sports Cream, and Troubled Skin, with line extensions planned for next year.
VANCOUVER, BRITISH COLUMBIA and LAS VEGAS, NV / ACCESSWIRE / November 5th, 2019 / Ovation Science Inc. (CSE:OVAT) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology backed by twenty-plus years of research and development, is pleased to announce that the Company's Chief Operating Officer and Co-Founder Doreen McMorran will be presenting at Dermatology Update 2019 Fall Meeting in Toronto Ontario, on November 7th on the topic "CBD - The New Market". This is the 35th year for this bi-annual dermatology conference which attracts the top 100+ dermatologists from across Canada. Dermatology Update is focused on presenting the latest advances in cosmetic and medical dermatology to practicing physicians, researchers and pharmaceutical industry leaders.
VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / October 15, 2019 / Ovation Science Inc. (CSE:OVAT) ("Ovation" or the "Company"), a cannabis product development company with a patented skin delivery technology backed by over twenty years of research and development, is pleased to announce that Ovation's product formulations, sold and marketed by its US licensee, achieved the distinction of three of the top five topical products sold in Nevada as of September 30th (by number of units sold). Notably, Ovation's 400 mg CBD transdermal wellness product remains the #1 topical product sold in Nevada. Ovation's 150 mg topical skincare product achieved the #4 spot while its transdermal 50mg CBD with 500 mg THC product was the 5th highest selling product in Nevada.
VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / September 25, 2019 / Ovation Science Inc. (CSE:OVAT) ("Ovation" or the "Company"), a cannabis product development company with a patented skin delivery technology backed by twenty-plus years of research and development, is pleased to announce that it has launched its e-commerce website www.ArloCBDBeauty.com featuring its anti-aging beauty line ARLO CBD Beauty. The website is designed for US consumers who want to purchase high quality anti-aging products infused with the benefits of CBD (Cannabidiol). "The launch of our e-commerce website for ARLO CBD Beauty products aligns with our Company's strategic vision for growth, expansion and revenue generation, said Doreen McMorran, Chief Operating Officer of Ovation.